SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016508
Filing Date
2023-10-18
Accepted
2023-10-18 07:05:11
Documents
15
Period of Report
2023-10-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20231018x8k.htm   iXBRL 8-K 35953
2 EX-99.1 gbio-20231018xex99d1.htm EX-99.1 115818
3 GRAPHIC gbio-20231018xex99d1001.jpg GRAPHIC 6101
4 GRAPHIC gbio-20231018xex99d1002.jpg GRAPHIC 27768
  Complete submission text file 0001558370-23-016508.txt   323491

Data Files

Seq Description Document Type Size
5 EX-101.SCH gbio-20231018.xsd EX-101.SCH 3194
6 EX-101.LAB gbio-20231018_lab.xml EX-101.LAB 12387
7 EX-101.PRE gbio-20231018_pre.xml EX-101.PRE 10665
9 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20231018x8k_htm.xml XML 4706
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 231330904
SIC: 2834 Pharmaceutical Preparations